The possibility that low high density lipoprotein (HDL) levels may add to the risk of occlusive atherosclerosis in familial hyperchoiesteroiemia (FH) is supported by the frequency and severity of this finding in these patients, particularly homozygotes. To investigate this abnormality in greater detail, we measured HDL lipid and apoprotein values in nine homozygotes with FH. Compared to their unaffected relatives, they had markedly reduced HDL cholesterol and apo A-l and A-ll levels. The values found in heterozygote relatives were between those of homozygotes and those of controls. Density gradient ultracentrifugation of serum or isolated HDL from homozygotes demonstrated little or no HDL 2 ; there was also a shift of homozygotes' HDL to an above normal peak density (d = 1.15 g/ml). Heterozygotes had milder abnormalities. The reduced HDL in FH seems to be related to elevated low density lipoprotein levels although the pathophysiology is unknown. These findings add weight to the concept that HDL abnormalities contribute to the relentless course of atherosclerosis in familial hyperchoiesteroiemia. (Arteriosclerosis 4:472-478, 
T he homozygous form of familial hyperchoiesteroiemia (FH) is characterized by extreme hyperchoiesteroiemia, the development of cutaneous xanthomata in childhood, and the occurrence of occlusive atherosclerotic vascular disease that is commonly fatal before age 20. 1 The disease is due to mutations of the gene that controls the cellular receptor for low density lipoprotein (LDL), which results in defective binding or internalization of this lipoprotein. Poorly regulated, receptor-independent pathways then form the predominant route for the uptake of LDL, which results in an excessive accumulation of cholesterol in the tissues. 2 The exact mechanism for the development of atherosclerosis in these patients is not well under-stood. Attention has understandably focused on the abnormalities of the LDL metabolism. However, the recognition that in the general population there is an inverse association between high density lipoproteins (HDL) and coronary artery disease raises the possibility that alterations in HDL metabolism may contribute to the complications of this disease. A large kindred with FH was studied 3 and it was concluded that a low level of HDL cholesterol was associated with an increased risk of ischemic heart disease and that this was independent of the LDL level.
The Afrikaans population in South Africa, predominantly of Dutch descent, has a high frequency of FH. 4 In a previous study of 34 patients from this group with the homozygous form of the disease, all patients were found to have reduced levels of HDL cholesterol. We now report more detailed studies of this abnormality.
Methods

Patients
Patients with FH attended the Lipid Disorders Clinic of the Johannesburg Hospital. The characteristics of these patients have been previously described. 4 The diagnosis of the heterozygous and homozygous states of the disease was based upon the criteria of Fredrickson and Levy. 1 Nine patients identified as having homozygous FH form the basis of this report. All had total cholesterol levels in excess of 600 mg/dl, clinical or biochemical evidence of the heterozygous state in both parents, and cutaneous xanthomas occurring before age 10. All except two patients had symptomatic coronary artery disease ( Table 1) . Two patients (sisters) were atypical in that, despite having all the phenotypic features of homozygous FH including severe symptomatic coronary artery disease as well as a positive family history, they were in their midforties. Both have children with the phenotypic feature of heterozygous FH. Fourteen patients with heterozygous FH who were relatives of the homozygote subjects were also studied. In addition, 43 unaffected family members and 42 unrelated normolipidemic individuals from the same population group provided control lipid values.
The forms of therapy received by the patients with homozygous FH are shown in Table 1 . Subjects with heterozygous FH were taking cholestyramine, probucol, or a combination of the two drugs. Several individuals either refused drug treatment or had not yet begun drug therapy. All patients were eating a standard low saturated fat, low cholesterol diet (P/S ratio = 0.5-1.0). All subjects gave informed consent for the study in accordance with institutional guidelines.
Laboratory Investigation
Blood samples were obtained from patients on the morning of their clinic visit after an overnight fast. Total cholesterol and triglyceride was measured in serum by Autoanalyzer methods, 5 end HDL cholesterol was quantitated in the supernatant obtained after precipitation of VLDL and LDL with sodium phosphotungstate and magnesium phloride. 6 Lipoprotein electrophoresis was performed on cellulose acetate. Aliquots of frozen and unfrozen serum vacuum packed in crushed ice were air-freighted within 24 hours to Chicago or Miami. Serum apo A-l, apo A-II, and apo B were measured by specific radioimmunoassays. 7 
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Ultracentrlfugatlon
Single-Step Density Gradient Ultracentrifugation
The lipoprotein profile of serum was obtained by means of a "single-step" density gradient ultracentrifugation according to a slightly modified procedure of Foreman et al. 10 The discontinuous gradient was prepared by weighing into an empty Beckman SW 40 rotor tube 0.5 g sucrose on which was layered, in sequence, 5 ml 4M NaCI, 0.5 ml serum, and 0.46M NaCI to the top of the tube. Centrifugation was performed for 66 hours at 39,000 rpm and 20° C, at which time isopycnic equilibrium was reached. The tubes were pumped out by using Fluorinert at a rate of 1 ml/min through an ISCO UA-5 monitor (Instrumentation Specialties, Lincoln, New Jersey) set at 280 nm. Densities of fractions from a control gradient were determined with a Precision Density Meter, DMA-02 (Anton Paar, Graz, Austria) as previously described. 11 Lp(a) was identified in the fractions obtained from the gradients either by SDS gel electrophoresis (4% acrylamide) or by double diffusion that used a specific antiserum to the Lp(a) antigen. 12
Isolation and Density Gradient Centrlfugatlon of HDL
HDL was isolated by a combination of rate-zonal and isopycnic equilibrium density gradient ultracentrifugation. Total lipoproteins were floated by adjusting serum to d = 1.21 g/liter with solid NaBr and by centrifuging for 20 hours in Ti 60 rotor (Beckman, Palo Alto, California) at 59,000 rpm. After the density of the isolated lipoproteins was adjusted to d = 1.4 g/ml with NaBr, the solution was layered under a linear 7.5% to 30% NaBr gradient. HDL was then separated from LDL at 20° C by centrifugation of the SW 40 rotor either at 20,000 rpm for 16 hours or at 35,000 rpm for 4 hours. Density gradient ultracentrifugation of HDL was subsequently carried out in a 7.5% to 20% NaBr gradient in the SW 40 rotor at 39,000 rpm, 20° C, and for 66 hours to isopycnic equilibrium. Gradients were pumped out with Fluorinert. Comparisons between groups were made by using the unpaired Student's nest, and correlations were assessed by linear regression.
Results
Relevant clinical data and serum lipid and apoprotein measurements in the patients with homozygous FH are shown in Table 1 . All nine patients exhibited marked elevations of serum total cholesterol and apo B values, and three had triglyceride levels greater than 180 mg/dl. Lipoprotein electrophoresis revealed intensely staining beta bands and very poor staining of the alpha band. All had very low HDL cholesterol levels and significantly reduced apo A-l and A-ll concentrations compared to normal values from our radioimmunoassay laboratory (p < 0.001). Apo A-l values were decreased to a greater degree than were apo A-ll levels (to 44% of normal for apo A-l, and 69% for apo A-ll). Despite the presence of severe hypoalphalipoproteinemia, a significant gender difference was observed in mean HDL cholesterol (females, 24 ± 3; males 16 ± 1 mg/dl, p = 0.05); a similar trend was noted for serum apo A-l (females, 61 ± 5; males, 46 ± 2mg/dl, 0.05 < p < 0.1), but not for apo A-ll (females, 17 ± 1; males, 20 ± 1 mg/dl).
Serum apo B levels were significantly higher (p < 0.001), and serum apo A-l (p < 0.001) and apo A-ll (p < 0.05) concentrations were lower, than those in the heterozygote relatives. The serum apo B, A-l, and A-ll in the heterozygote patients were significantly different from normal (p < 0.001). Table 2 tabulates the serum triglyceride, total cholesterol, and HDL cholesterol values in the homozygote patients and in groups of their heterozygote and unaffected relatives. Results from 41 unrelated control subjects from the same population group are shown. The homozygotes had markedly elevated total cholesterol and reduced HDL cholesterol values. In addition, homozygotes' mean serum triglyceride concentration was slightly higher. The mean total and HDL cholesterol values of the heterozygote group lay between the control and homozygote FH means. There were no differences in lipid values between the unaffected relatives and the unrelated control group.
Within the group of homozygote patients, HDL cholesterol values were not correlated with serum triglyceride, total cholesterol, or apo B values. However, serum apo A-l (but not apo A-ll) levels tended to vary inversely with both the apo B (r = -0.62) and total cholesterol (r = -0.59) concentrations (0.05 < To examine the distribution of serum lipoproteins and HDL, we subjected serum to "single-spin" density gradient ultracentrifugation. The optical density profiles of serum lipoprotein distributions in patients with homozygous FH from three different families, together with those from their normolipidemic and heterozygous relatives, are shown in Figure 1 A-C. Figure 1 D illustrates the profiles from three other homozygotes. In addition to the markedly expanded LDL section of the gradients, the sera from the individuals with homozygous FH are striking for the profound reduction of HDL. Many of the heterozygotes studied in this way also demonstrated reduced amounts of HDL, usually of a milder degree than that observed among the homozygotes. Of equal importance appears to be the alteration in distribution of HDL, with the higher density subtractions predominating in the sera of some of the heterozygotes. This was pronounced in the individuals with homozygous FH. Coupled with the reduction in the concentration of HDL, the increase in density created a lipoprotein profile essentially devoid of HDL peaks and one that could not be separated from the bottom fraction. The lipoprotein bands located between density 1.06 to 1.09 are not HDL but actually Lp(a). Figure 2 contrasts the distribution of apo B, A-l, and A-ll in serum centrifuged through the gradient in a normal individual with that from his sibling with homozygous FH. As expected, there is an extremely large peak of apo B immunoreactivity in the gradient from the patient. The apo A-l and A-ll profiles are both reduced in amount, and the peak fractions are shifted to higher density as compared with the normolipidemic subject. Especially evident is the marked reduction of apo A-l in the lighter density fractions of HDL (d = 1.07-1.11), while a decrement in apo A-l in the heavier fractions (d = 1.12-1.18) is much less obvious.
These features are further illustrated in Figure 3 , which depicts the optical density and apoprotein profiles of HDL isolated from the serum of a normolipide-4-, In each case, the HDL from an equal starting volume of serum was centrifuged to equilibrium through a 7.5% to 20% NaBr density gradient. Once again, the reduced amount of HDL is apparent, particularly in the d = 1.07-1.12 fractions corresponding to HDLj. The HDL from the heterozygote, in contrast to the control, appeared to be mainly HDL3 (d = 1.12-1.21) with little HDL,, whereas the HDL of the homozygous patient was even denser than the HDLg in her heterozygous sibling.
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Discussion
The finding that patients with homozygous FH have reduced HDL levels was originally noted by Gofman et al. in 1954. 13 Since then most reports (including this one) have confirmed this observation. 1314 - 19 An earlier report 4 drew attention to the fact that all 34 homozygous FH patients seen in the clinic had HDL cholesterol values below 34 mg/dl (mean ± SEM, 23 ± 1 mg/dl). The results obtained here demonstrate that the decreased HDL cholesterol values were accompanied by a marked reduction in the serum concentrations of the major HDL apo-proteins, apo A-l, and apo A-ll, over 90% of which form the bulk of apo HDL. 20 Several studies 121 have also noted that heterozygotes with FH have modestly reduced HDL cholesterol levels. Similar findings 22 have been made in the cord blood of infants with FH. In support of these data, the HDL cholesterol and serum apo A-l and A-ll values were significantly decreased compared to controls in the small group of heterozygous relatives of the homozygote probands studied here. On the other hand, unaffected family members did not have reduced HDL cholesterol levels compared to unrelated controls. Three of the homozygotes had mildly increased triglyceride values. An inverse correlation between triglyceride and HDL cholesterol concentrations is well described, 23 but no such association was noted in these patients.
The influence of treatment has to be considered as a possible determinant of the HDL profile. 24 -27 In particular, probucol has been shown to lower HDL levels. However, the lipoprotein profiles and HDL cholesterol and apoprotein levels were similar regardless of the treatment form used. Further, the five patients receiving probucol were part of a previous study that investigated the effect of this drug on serum lipids. No persistent reduction in the HDL cho-lesterol values, which were low before drug treatment, resulted from probucol therapy in that report. 28 Apart from isolated case reports, 26 ' M the only large series describing normal HDL cholesterol values in homozygous FH patients is that by Kachadurian and Uthman. 31 The mean ( ± SD) HDL cholesterol value in that study of 52 such individuals was 53 ± 36 mg/dl with a range of 17 to 140 mg/dl. While there is no obvious explanation for this difference in results, we have found 4 that the heparin-manganese chloride method used by these authors to remove VLDL and LDL did not always precipitate the very large amounts of LDL found in homozygotes and resulted in falsely raised values for HDL cholesterol.
The marked decrease in the level of the major HDL apoprotein, apo A-l, clearly reduces the amount of cholesterol that can be carried by HDL. Further studies are needed to determine whether this is due to lowered rates of apo A-l synthesis or to enhanced catabolism. However, in addition to a reduction in the absolute amount of HDL, there were important qualitative alterations in this lipoprotein class. It was found that serum apo A-l levels were reduced to a greater extent than apo A-ll. These results suggest a disproportionate reduction in the HDL, subfraction, since this segment of the HDL density range (d = 1.063-1.12) is relatively enriched in apo A-l. 31 Density gradient ultracentrifugation of both serum, as well as isolated HDL, from selected patients confirmed that there was an overall decrease in the amount of HDL in the homozygote FH patients and, in addition, a more prominent reduction in the lighter density fractions of this lipoprotein class, which corresponds with the HDL, density range. These findings are similar to those noted in two homozygote FH patients by Patsch et al. 19 In addition to the changes in the HDL, fraction, the peak density of HDL was increased to d = 1.15 g/ml, which is higher than that of normal HDL3.
It is well known 32 that there is a negative sizedensity relationship for HDL. This would predict that the relatively dense HDL species of these patients are, on average, smaller than normal in size and therefore might have a reduced capacity to carry cholesterol. It is also of interest that a similar lipoprotein profile (namely, greatly elevated LDL and reduced levels of HDL that are much denser than normal) occurs in rhesus monkeys with diet-induced hypercholesterolemia. 33 ' M Since these animals are not LDL receptor-deficient, this raises the possibility that the perturbation of HDL concentration and density may not be the result of defective LDL processing by the LDL receptor, but could be related in some other way to the elevated LDL levels.
The pathogenesis of these HDL abnormalities will require further study. However, their implications are important. Regardless of the gross elevation of LDL, the marked deficiency of HDL, among the homozygotes would predict an increase in the risk of atherosclerosis, in view of the evidence that the HDL, subfraction of HDL is the key component that deter-mines the inverse correlation of HDL with ischemic heart disease. 35 At the cellular level, HDL has been demonstrated to promote net cellular cholesterol efflux and thus helps to protect the cell from cholesterol accumulation. It has recently been demonstrated 36 that the net efflux of cholesterol from cultured cells is reduced in the presence of FH serum, an effect thought to be related to abnormalities of the HDL fraction. Our demonstration that there are qualitative and quantitative aberrations in the HDL class from FH patients may provide an explanation for this anomaly and supports the concept that both the LDL excess, and in many patients, an HDL deficiency contribute to the high risk of atherosclerosis in this condition.
